Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson’s Disease
Heejeong Kim(Samsung Medical Center), Yunjong Lee(Sungkyunkwan University), Han‐Joo Maeng(Gachon University), Yohan Oh(Hanyang University), Seung‐Mann Paek(Gyeongsang National University), Ji Hun Kim(Pohang University of Science and Technology), Jin‐Ha Yoon(Yonsei University)
Cited by 4
Related Papers
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
|Nature Medicine|2018|1.2k
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
|Cell|2011|951
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
|Proceedings of the National Academy of Sciences|2010|282
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
|Proceedings of the National Academy of Sciences|2011|263
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
|Proceedings of the National Academy of Sciences|2015|259